(Q37777434)

23 August 2017

title

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients (English)

1 reference

23 August 2017

0 references

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

viral drug resistance

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

2

F. M. Marty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

author name string

R. K. Avery

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

L. Strasfeld

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

I. Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

A. Arrieta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

S. Chou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

W. Tatarowicz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

S. Villano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682012

16 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20682012

16 June 2024

publication date

1 December 2010

1 reference

full work available at URL

23 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1399-3062.2010.00550.x

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3062.2010.00550.x/fullpdf

16 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Transplant Infectious Disease

16 June 2024

published in

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

489-496

1 reference

23 August 2017

cites work

Controlling the troll

1

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Persistent clinical impact of cytomegalovirus in organ transplantation.

16 June 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

16 June 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Cytomegalovirus (CMV) resistance to antivirals

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection

16 June 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Update in management of ganciclovir-resistant cytomegalovirus infection

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects

16 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir

16 June 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients

16 June 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

16 June 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients

16 June 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

16 June 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide

16 June 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1399-3062.2010.00550.X

16 June 2024

Identifiers

1 reference

23 August 2017

1 reference